Cytotoxicity Of Chalcone Of Eugeniaaquea Burm F. Leaves Against T47D Breast Cancer Cell Lines And Its Prediction As An Estrogen Receptor Antagonist Based On Pharmacophore-Molecular Dynamics Simulation

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016;17(S3):43–46. doi:10.7314/APJCP.2016.17.S3.43
   PubMedGoogle Scholar
• Zhu HH, Hu CH, Strickland P. Perspectives of breast cancer etiology: synergistic interaction between smoking and exogenous hormone use. Chin J Cancer. 2011;30(7):433–441.21718589
   PubMedGoogle Scholar
• Boonyaratanakornkit V, Pateetin P. The role of ovarian sex steroids in metabolic homeostasis, obesity, and postmenopausal breast cancer: molecular mechanisms and therapeutic implications. Biomed Res Int. 2015;2015:140196. doi:10.1155/2015/14019625866757
   PubMed Web of Science ®Google Scholar
• Arslan AA, Shore RE, Afanasyeva Y, Koenig KL, Toniolo P, Zeleniuch-Jacquotte A. Circulating estrogen metabolites and risk for breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2273–2279. doi:10.1158/1055-9965.EPI-09-031219661086
   PubMed Web of Science ®Google Scholar
• Ziegler RG, Fuhrman BJ, Moore SC, Matthews CE. Epidemiologic studies of estrogen metabolism and breast cancer. Steroids. 2015;99(Pt A):67–75. doi:10.1016/j.steroids.2015.02.01525725255
   PubMed Web of Science ®Google Scholar
• Farooq A. Structural and functional diversity of estrogen receptor ligands. Curr Top Med Chem. 2015;15(14):1372–1384. doi:10.2174/156802661566615041315484125866274
   PubMed Web of Science ®Google Scholar
• Martinkovich S, Shah D, Planey SL, Arnott JA. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging. 2014;9:1437–1452. doi:10.2147/CIA.S6669025210448
   PubMed Web of Science ®Google Scholar
• Lewis DK, Johnson AB, Stohlgren S, Harms A, Sohrabji F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J Neuroimmunol. 2008;195(1–2):47–59. doi:10.1016/j.jneuroim.2008.01.00618328572
   PubMed Web of Science ®Google Scholar
• Zhou Z, Qiao JX, Shetty A, et al. Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. Cell Mol Life Sci. 2014;71(8):1549.
   PubMedGoogle Scholar
• Marino M, Galluzzo P, Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics. 2006;7(8):497–508. doi:10.2174/13892020677931573718369406
   PubMed Web of Science ®Google Scholar
• Oseni T, Patel R, Pyle J, Jordan VC. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008;74(13):1656–1665. doi:10.1055/s-0028-108830418843590
   PubMed Web of Science ®Google Scholar
• Marino M, Galluzzo P. Are flavonoids agonists or antagonists of the natural hormone 17beta-estradiol? IUBMB Life. 2008;60(4):241–244. doi:10.1002/iub.3418344194
   PubMed Web of Science ®Google Scholar
• Sliwoski G, Kothiwale S, Meiler J, Lowe EW Jr. Computational methods in drug discovery. Pharmacol Rev. 2014;66(1):334–395. doi:10.1124/pr.112.00733624381236
   PubMed Web of Science ®Google Scholar
• Kayl AE, Meyers CA. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol. 2006;18(1):24–28. doi:10.1097/01.gco.0000192996.20040.2416493256
   PubMed Web of Science ®Google Scholar
• Newman D. Screening and identification of novel biologically active natural compounds. F1000Research. 2017;6:783. doi:10.12688/f1000research28649374
   PubMedGoogle Scholar
• Subarnas A, Diantini A, Abdulah R, et al. Apoptosis induced in MCF-7 human breast cancer cells by 2ʹ, 4ʹ-dihydroxy-6-methoxy-3, 5-dimethylchalcone isolated from eugenia aquea burm f. leaves. Oncol Lett. 2015;9(5):2303–2306. doi:10.3892/ol.2015.298126137061
   PubMed Web of Science ®Google Scholar
• Muchtaridi M, Syahidah H, Subarnas A, Yusuf M, Bryant S, Langer T. Molecular docking and 3D-pharmacophore modeling to study the interactions of chalcone derivatives with estrogen receptor alpha. Pharmaceuticals. 2017;10(4):81. doi:10.3390/ph10040081
   Web of Science ®Google Scholar
• Miller CP. SERMs: evolutionary chemistry, revolutionary biology. Curr Pharm Des. 2002;8(23):2089–2111. doi:10.2174/138161202339340412171520
   PubMed Web of Science ®Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 03. Wallingford, CT: Gaussian, Inc; 2003.
   Google Scholar
• Wolber G, Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model. 2005;45(1):160–169. doi:10.1021/ci049885e15667141
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461. doi:10.1002/jcc.2133419499576
   PubMed Web of Science ®Google Scholar
• Accelrys. Discovery Studio Modeling Environment, Release 3.5. San Diego: Accelrys Software Inc; 2007.
   Google Scholar
• Case DA, Cheatham TE III, Darden T, et al. Amber 11. San Francisco: University of California; 2010.
   Google Scholar
• Yin LM, Wei Y, Wang WQ, Wang Y, Xu YD, Yang YQ. Simultaneous application of BrdU and WST-1 measurements for detection of the proliferation and viability of airway smooth muscle cells. Biol Res. 2014;47:75. doi:10.1186/0717-6287-47-7525723317
   PubMed Web of Science ®Google Scholar
• Han SB, Shin YJ, Hyon JY, Wee WR. Cytotoxicity of voriconazole on cultured human corneal endothelial cells. Antimicrob Agents Chemother. 2011;55(10):4519–4523. doi:10.1128/AAC.00569-1121768517
   PubMed Web of Science ®Google Scholar
• Scott J, Weiner SJ, Kollman PA, et al. A new force field for molecular mechanical simulation of nucleic acids and proteins. J Amer Chem Soc. 1984;106(3):765–784. doi:10.1021/ja00315a051
   Web of Science ®Google Scholar
• Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity – a rapid access to atomic charges. Tetrahedron. 1980;36:3219–3228. doi:10.1016/0040-4020(80)80168-2
   Web of Science ®Google Scholar
• Ikram NK, Durrant JD, Muchtaridi M, et al. A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity. J Chem Inf Model. 2015;55(2):308–316. doi:10.1021/ci500405g25555059
   PubMed Web of Science ®Google Scholar
• Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem. 2012;55(14):6582–6594. doi:10.1021/jm300687e22716043
   PubMed Web of Science ®Google Scholar
• Accelrys. Discovery Studio Modeling Environment, Release 2.5.5. San Diego: Accelrys Software Inc; 2007.
   Google Scholar
• Duan Y, Wu C, Chowdhury S, et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Compu Chem. 2003;24(16):1999–2012. doi:10.1002/jcc.10349
   PubMed Web of Science ®Google Scholar
• Muchtaridi M, Yusuf M, Diantini A, et al. Potential activity of fevicordin-A from phaleria macrocarpa (Scheff) boerl. Seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies. Int J Mol Sci. 2014;15(5):7225. doi:10.3390/ijms1505722524776765
   PubMed Web of Science ®Google Scholar
• Subarnas A. Antiproliferative activity of primates-consumed plants against MCF-7 human breast cancer cell lines. E3 J Med Res. 2012;1(4):038–043.
   Google Scholar
• Yang S, Zhou Q, Yang X. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys Acta Mol Cell Res. 2007;1773(6):903–911. doi:10.1016/j.bbamcr.2007.03.021
   PubMed Web of Science ®Google Scholar
• Mooney LM, Al-Sakkaf KA, Brown BL, Dobson PRM. Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells. Br J Cancer. 2002;87(8):909–917. doi:10.1038/sj.bjc.660054112373608
   PubMed Web of Science ®Google Scholar
• Devarajan E, Sahin AA, Chen JS, et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene. 2002;21(57):8843–8851.12483536
   PubMed Web of Science ®Google Scholar
• Celik L, Lund JD, Schiott B. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics. Biochemistry. 2007;46(7):1743–1758.17249692
   PubMed Web of Science ®Google Scholar
• Hu R, Hilakivi-Clarke L, Clarke R. Molecular mechanisms of tamoxifen-associated endometrial cancer (Review). Oncol Lett. 2015;9(4):1495–1501. doi:10.3892/ol.2015.296225788989
   PubMed Web of Science ®Google Scholar
• Eiler S, Gangloff M, Duclaud S, Moras D, Ruff M. Overexpression, purification, and crystal structure of native ER alpha LBD. Protein Expr Purif. 2001;22(2):165–173. doi:10.1006/prep.2001.140911437591
   PubMed Web of Science ®Google Scholar
• Shiau AK, Barstad D, Loria PM, et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1998;95(7):927–937. doi:10.1016/S0092-8674(00)81717-19875847
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and autodocktools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–2791. doi:10.1002/jcc.v30:1619399780
   PubMed Web of Science ®Google Scholar
• Musfiroh I, Muchtaridi M, Muhtadi A, et al. Cytotoxicity studies of xanthorrhizol and its mechanism using molecular docking simulation and pharmacophore modelling. J Appl Pharm Sci. 2013;3(06):007–015.
   Google Scholar
• Celik L, Lund JDD, Schiøtt B. Conformational Dynamics of the estrogen receptor α: molecular dynamics simulations of the influence of binding site structure on protein dynamics. Biochemistry. 2007;46(7):1743–1758. doi:10.1021/bi061656t17249692
   PubMed Web of Science ®Google Scholar
• Mysinger MM, Carchia M, Irwin JJ, Shoichet BK, Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem. 2012;55(14):6582–6594. doi:10.1021/jm300687e22716043
   PubMed Web of Science ®Google Scholar
• Huang N, Shoichet BK, Irwin JJ. Benchmarking sets for molecular docking. J Med Chem. 2006;49(23):6789–6801. doi:10.1021/jm060835617154509
   PubMed Web of Science ®Google Scholar
• Gaulton A, Bellis LJ, Bento AP, et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012;40(Database issue):D1100–D1107.21948594
   PubMed Web of Science ®Google Scholar
• Zamri A, Teruna H, Ikhtiarudin I. The influences of power variations on selectivity of synthesis reaction of 2ʹ-hydroxychalcone analogue under microwave irradiation. Molekul. 2016;11(2):299–307. doi:10.20884/1.jm.2016.11.2.220
   Google Scholar